Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Molecular Weight of Step-Growth Polymers01:08

Molecular Weight of Step-Growth Polymers

2.1K
Step growth polymerization involves bi or multifunctional monomers. Bifunctional monomers react to form linear step growth polymers, whereas multifunctional monomers react to form non-linear or branched polymers.
As the step-growth polymerization involves step-wise condensation of monomers, the molecular weight also builds up eventually. Consequently, high molecular weight polymers are obtained at the late stages of the polymerization, where 99% of monomers have been consumed.
The extent of the...
2.1K
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence01:27

Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence

226
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
226
Factors Influencing Drug Absorption: Pharmaceutical Parameters01:28

Factors Influencing Drug Absorption: Pharmaceutical Parameters

835
Solid dosage forms such as tablets and capsules undergo rigorous manufacturing processes to ensure stability and effectiveness. Their dissolution and absorption properties are influenced significantly by the choice of excipients (inactive ingredients that serve various roles in the formulation), and the methodology applied during production. The manufacturing parameters, such as compression force and granulation techniques, significantly affect dissolution rates. Elevated compression forces...
835
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules01:18

Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules

421
Bioequivalence in generic drugs, such as tablets and capsules, refers to their pharmaceutical equivalence to the brand-name counterparts. However, for therapeutic equivalence, manufacturers must also consider physical attributes like size, shape, and weight (FDA Guidance for Industry, December 2003). Discrepancies in these aspects could impact patient compliance and cause medication errors. For instance, swallowing difficulties, often experienced with larger tablets or capsules, can lead to...
421
One-Compartment Open Model for IV Bolus Administration: General Considerations01:19

One-Compartment Open Model for IV Bolus Administration: General Considerations

1.1K
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
1.1K
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

139
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
139

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prescription - Dermatology and Wound Care.

International journal of pharmaceutical compounding·2024
Same author

Prescription: Technology in Compounding.

International journal of pharmaceutical compounding·2024
Same author

Pharmaceutical Waters Used in Sterile and Nonsterile Compounding.

International journal of pharmaceutical compounding·2024
Same author

Quality Control: Water Activity Considerations for Beyond-use Dates.

International journal of pharmaceutical compounding·2024
Same author

Prescription: Pediatric/Geriatric.

International journal of pharmaceutical compounding·2024
Same author

Basics of Compounding: Tips and Hints, Part 4: Lollipops/Lozenges, Gummy Bears, Patches, Flavoring/Coloring, Sweeteners, and Packaging.

International journal of pharmaceutical compounding·2024

Related Experiment Video

Updated: May 5, 2026

Preparation of Carbon Fiber and Bamboo Fiber Reinforced Poly (butylene Adipate-co-terephthalate) Foams by Supercritical Carbon Dioxide Foaming
07:56

Preparation of Carbon Fiber and Bamboo Fiber Reinforced Poly (butylene Adipate-co-terephthalate) Foams by Supercritical Carbon Dioxide Foaming

Published on: October 10, 2025

415

Basics of compounding foam dosage forms.

Loyd V Allen1

  • 1International Journal of Pharmaceutical Compounding, Edmond, Oklahoma 73034, USA. lallen@ijpc.com

International Journal of Pharmaceutical Compounding
|November 23, 2013
PubMed
Summary
This summary is machine-generated.

This article explores pharmaceutical foam dosage forms, detailing their benefits and preparation. It guides pharmacists on extemporaneously compounding these versatile formulations for improved drug delivery.

More Related Videos

Casting Protocols for the Production of Open Cell Aluminum Foams by the Replication Technique and the Effect on Porosity
09:22

Casting Protocols for the Production of Open Cell Aluminum Foams by the Replication Technique and the Effect on Porosity

Published on: December 11, 2014

14.2K
Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms
11:19

Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms

Published on: April 11, 2017

15.9K

Related Experiment Videos

Last Updated: May 5, 2026

Preparation of Carbon Fiber and Bamboo Fiber Reinforced Poly (butylene Adipate-co-terephthalate) Foams by Supercritical Carbon Dioxide Foaming
07:56

Preparation of Carbon Fiber and Bamboo Fiber Reinforced Poly (butylene Adipate-co-terephthalate) Foams by Supercritical Carbon Dioxide Foaming

Published on: October 10, 2025

415
Casting Protocols for the Production of Open Cell Aluminum Foams by the Replication Technique and the Effect on Porosity
09:22

Casting Protocols for the Production of Open Cell Aluminum Foams by the Replication Technique and the Effect on Porosity

Published on: December 11, 2014

14.2K
Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms
11:19

Fabrication of Extracellular Matrix-derived Foams and Microcarriers as Tissue-specific Cell Culture and Delivery Platforms

Published on: April 11, 2017

15.9K

Area of Science:

  • Pharmaceutical Sciences
  • Drug Delivery Systems

Background:

  • Foams offer unique advantages in drug delivery.
  • Understanding foam characteristics is crucial for effective pharmaceutical applications.

Purpose of the Study:

  • To provide comprehensive information on foam dosage forms.
  • To educate pharmacists on the extemporaneous compounding of pharmaceutical foams.

Main Methods:

  • Discussion of the rationale and benefits of using foams.
  • Differentiation of various foam types and structures.
  • Listing of ingredients and examples for foam preparation.
  • Description of pharmaceutical foam preparation techniques.

Main Results:

  • Foams present a viable and advantageous dosage form.
  • Pharmacists can effectively compound pharmaceutical foams extemporaneously.
  • Various ingredients and methods facilitate foam formulation.

Conclusions:

  • Foam dosage forms are versatile and beneficial in pharmacy practice.
  • Extemporaneous compounding of foams expands pharmacists' capabilities.
  • Knowledge of foam components and preparation is essential for successful formulation.